Cardiovascular effects of xylazine recorded with telemetry in the dog

Journal of Veterinary Medicine Series A: Physiology Pathology Clinical Medicine

Volumn 50, Issue 10, 2003, Pages 479-483

  Ilback N G ^a,b   Stalhandske T ^a,c  

^a NATIONAL FOOD ADMINISTRATION   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c Active Biotech Research AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS;

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; XYLAZINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD PRESSURE; DOG; DRUG EFFECT; FEMALE; HEART RATE; INTRAMUSCULAR DRUG ADMINISTRATION; PHYSIOLOGY; TELEMETRY;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; BLOOD PRESSURE; DOGS; FEMALE; HEART RATE; INJECTIONS, INTRAMUSCULAR; TELEMETRY; XYLAZINE;

EID: 3042723700     PISSN: 0931184X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0442.2004.00585.x     Document Type: Article

References (22)

1. Brockway, B. P., P. A. Mills, and S. H. Azar, 1991: A new method for continuous chronic measurements and recording of blood pressure, heart rate and activity in the rat via radio-telemetry. Clin. Exp. Hypertens. 13, 885-895.
2. Eisermann, K. 1988: Seasonal and environmental influences upon the diurnal heart rate pattern in wild rabbits living under seminatural conditions. Physiol. Behav. 43, 559-565.
3. Garcia-Villar, R., P. L. Toutain, M. Alvinerie, and Y. Ruckebusch, 1981: The pharmacokinetics of xylazine hydrochloride: an interspecific study. J. Vet. Pharmacol. Ther. 4, 87-92.
4. Gelzer, A. R., and H. A. Ball, 1997: Validation of a telemetry system for measurement of blood pressure, electrocardiogram and locomotor activity in beagle dogs. Clin. Exp. Hypertens. 19, 1135-1160.
5. Grant, C., G. E. Summersides, and T. R. Kuchel, 2001: A xylazine infusion regimen to provide analgesia in sheep. Lab. Anim. 35,277-281.
6. Greaves, P., 1998: Patterns of drug induced cardiovascular pathology in the beagle dog: relevance for humans. Exp. Toxicol. Pathol. 50, 283-293.
7. Greene, S. A., and J. C. Thurmon, 1988: Xylazine: a review of its pharmacology and use in veterinary medicine. J. Vet. Pharmacol. Ther. 11, 295-313.
8. Greene, S. A., R. D. Keegan, and A. B. Weil, 1995: Cardiovascular effects after epidural injection of xylazine in isoflurane-anaesthetized dogs. Vet. Surg. 24, 283-289.
9. Haskins, S. C., J. D. Patz, and T. B. Farver, 1986: Xylazine and xylazine-ketamine in dogs. Am. J. Vet. Res. 47, 636-641.
10. Hatch, R. C., J. D. Clark, N. H. Booth, and J. V. Kitzman, 1983: Comparison of five preanesthetic medicaments in pentobarbital-anesthetized dogs: antagonism by 4-aminopyridine, yohimbine and naloxane. Am. J. Vet. Res. 44, 2312-2319.
11. Ilbäck, N.-G., T. Stålhandske, and U. Lindh, 2000: Effects of EDTA on trace elements and cardiovascular function in the anaesthetized rabbit. Biol. Trace Elem. Res. 76, 133-148.
12. Ilbäck, N.-G., K. Gunnarsson, and T. Stålhandske, 2002a: Effects of rhIGF-I and insulin induced hypoglycaemia on cardiovascular parameters recorded with telemetry in the conscious dog. Pharmacol Toxicol 90, 73-81.
13. Ilbäck, N.-G., R. Persson, K. Gunnarsson, and T. Stålhandske, 2002b: A new screening model for safety evaluation of superantigen-antibody recombinant fusion proteins (r-C242 Fab-SEA/E) using telemetric monitoring in conscious rabbits. J. Pharmacol. Toxicol. Methods 48, 31-39.
14. Ilbäck, N.-G., K. Gunnarsson, R. Persson, U. Lindh, and T. Stålhandske, 2003: Effects of a superantigen-antibody recombinant fusion protein (r-C242 Fab-SEA) on toxicological responses in the anaesthetized rabbit. Toxicology 185, 161-174.
15. Klide, A. M., H. W. Calderwood, and L. R. Soma, 1975: Cardiopulmonary effects of xylazine in dogs. Am. J. Vet. Res. 36, 931-935.
16. Lange, J. B., B. Brockway, and S. Azar, 1991: Telemetric monitoring of laboratory animals: an advanced technique that has come of age. Lab. Anim. 20, 28-33.
17. MacLean, M. R., and C. R. Hiley, 1988: Effects of enalapril on changes in cardiac output and organ vascular resistances induced by alpha 1- and alpha 2-adrenoceptor agonists in pithed normotensive rats. Br. J. Pharmacol. 94, 449-462.
18. Rector, E., K. Otto, M. Kietzman, I. Nolte, and W. Lehmacher, 1996: Pharmacokinetics and effects of xylazine (Rompun) in dogs. Berl. Munch. Tierartz. Wochenschr. 109, 18-22.
19. Rector, A. A., S. Kramer, M. Kietzman, S. Hart, and I. Nolte, 1998: Beurteilung der antinozizeptiven wirkung von systemisch und epidural appliziertem xylazin in allgemeinanasthesie mit isofluran bei hunden sowie auswirkungen der atipamezolgabe auf der post-operative analgesie. Berl. Munch. Tierartz. Wochenschr. 111, 438-451.
20. Tallarida, R. J., and R. B. Murray, 1987: Manual of Pharmacological Calculations with Computer Program. Springer Verlag, London.
21. Truett, A. A., and D. B. West, 1995: Validation of radio telemetry system for continuous blood pressure and heart rate monitoring in dogs. Lab. Anim. Sci. 45, 299-302.
22. Tyner, C. L., B. J. Woody, J. S. Reid, E. P. Chafetz, H. A. Lederer, J. F. Norton, T. J. Keefe, and W. Jochle, 1997: Multicenter clinical comparison of sedative and analgesic effects of medetomidine and xylazine in dogs. J. Am. Vet. Med. Assoc. 211, 1413-1417.